Vaccination against the human papillomavirus (HPV) remains limited in Africa despite the continent’s high burden of cervical cancer, according to presenters at the recent Africa Human Papillomavirus summit.
Each year in Africa, 119 284 women are diagnosed with cervical cancer and 81 687 die of the disease, according to the HPV Information Centre. Sub-Saharan Africa alone bears 20% of the world’s cervical cancer burden, said Sharon Kapambwe, MBChB, MPH, national coordinator for cancer prevention in Zambia’s Ministry of Health. Yet only 14 of the continent’s 54 countries have national HPV vaccination programs.
Kuehn B. Summit Leaders Urge Greater HPV Vaccination in Africa. JAMA. 2019;322(19):1853. doi:10.1001/jama.2019.17713
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: